Remote Northeast Medical Science Liaison (Hematology)

Disc Medicine; United States; Hybrid; USD 186,000 - 228,000; Full time

Job summary

Disc Medicine is seeking a field-based Medical Science Liaison (MSL) to cover the Northeast territory (ME, NH, VT, MA, CT, RI, NY) with a flexible remote/hybrid work setup, including the Watertown, MA area.

You will build and maintain scientific relationships with KOLs and HCPs, support clinical development programs, and contribute to publications, education, and identifying unmet patient needs across hematology and related diseases.

Qualifications

• Advanced clinical or scientific degree (PharmD, PhD, MD, DO, DNP, or MSc) or equivalent credentials.
• 3+ years of biopharmaceutical industry experience as an MSL or in a related field-based medical affairs role.
• Experience in hematology, dermatology, or rare disease preferred; product launch experience strongly preferred.
• Excellent communication and presentation skills; ability to convey complex scientific concepts clearly.

Responsibilities

• Engage in scientific exchange with KOLs and HCPs across hematology, dermatology, hepatology, and the rare disease communities.
• Support company-sponsored trials, investigator-initiated trials (IITs), research collaborations, and expanded access.
• Gather and communicate actionable field insights from KOL and HCP interactions to inform medical strategy; plan regional advisory boards.
• Collaborate with cross-functional teams and ensure compliance with regulatory guidelines.

Skills

Communication

Presentation skills

Analytical thinking

Territory planning

Education

Advanced clinical or scientific degree (PharmD, PhD, MD, DO, DNP, MSc) or equivalent credentials

Job description

Disc Medicine is seeking a field-based Medical Science Liaison (MSL) to cover the Northeast territory (ME, NH, VT, MA, CT, RI, NY) with a flexible remote/hybrid work setup, including the Watertown, MA area.

You will build and maintain scientific relationships with KOLs and HCPs, support clinical development programs, and contribute to publications, education, and identifying unmet patient needs across hematology and related diseases.